BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 33688998)

  • 1. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
    Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
    Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
    J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
    Zou Y; Xu L; Wang W; Zhu X; Lin J; Li H; Chen J; Xu W; Gao H; Wu X; Yin Z; Wang Q
    Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
    Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
    J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma.
    Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M
    Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
    Kataoka Y; Mukohara T; Tomioka H; Funakoshi Y; Kiyota N; Fujiwara Y; Yashiro M; Hirakawa K; Hirai M; Minami H
    Invest New Drugs; 2012 Aug; 30(4):1352-60. PubMed ID: 21655918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
    Zillhardt M; Park SM; Romero IL; Sawada K; Montag A; Krausz T; Yamada SD; Peter ME; Lengyel E
    Clin Cancer Res; 2011 Jun; 17(12):4042-51. PubMed ID: 21551255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition.
    Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of Baicalin with Knockdown of
    Paul-Samojedny M; Liduk E; Kowalczyk M; Borkowska P; Zielińska A; Suchanek-Raif R; Kowalski J
    Curr Pharm Biotechnol; 2023; 24(5):686-697. PubMed ID: 35761505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
    Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
    BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma.
    Zhou L; Tang H; Wang F; Ou S; Wu T; Fang Y; Xu J; Guo K
    Oncol Rep; 2020 Mar; 43(3):807-816. PubMed ID: 32020219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulforaphane Causes Cell Cycle Arrest and Apoptosis in Human Glioblastoma U87MG and U373MG Cell Lines under Hypoxic Conditions.
    Sita G; Graziosi A; Hrelia P; Morroni F
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).
    Li J; Tang H; Zhang Y; Tang C; Li B; Wang Y; Gao Z; Luo P; Yin A; Wang X; Cheng G; Fei Z
    PLoS One; 2013; 8(11):e81258. PubMed ID: 24278406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells.
    Liu L; Shi H; Liu Y; Anderson A; Peterson J; Greger J; Martin AM; Gilmer TM
    Mol Cancer Ther; 2011 Mar; 10(3):518-30. PubMed ID: 21252284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-Met-mediated epithelial-mesenchymal transition.
    Hei B; Wang J; Wu G; Ouyang J; Liu RE
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1270-1277. PubMed ID: 31113618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
    Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
    Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.